High-Level Overview
Serenis Health is an Italian digital health startup founded in 2021 that provides accessible online mental health services, including video-based psychotherapy, psychiatric evaluations, personal coaching, clinical sexology, nutritional guidance, and corporate wellbeing programs.[1][2][3][6] It serves individuals facing everyday stress or serious mental health issues, as well as over 250 corporate clients like Nestlé and Satispay, by matching users with licensed professionals via data analytics for personalized care.[1][2][4] The platform solves accessibility barriers, stigma, and high costs in mental healthcare—offering three initial free sessions, therapist flexibility, and affordable pricing—while demonstrating explosive growth: revenues rose from €2M in 2022 to €25M in 2024 with a €40M+ run-rate projected for 2025, over 170,000 users supported via 1.5 million sessions, and a network of 2,500+ professionals.[2][4]
Origin Story
Serenis was co-founded in 2021 by Silvia Wang and Daniele Francescon in Milan, Italy, emerging from a commitment to address Italy's undervalued mental health landscape where stigma silences open discussion.[1][2] The idea crystallized amid rising awareness of mental health needs post-pandemic, leading to rapid early traction: within one year, it raised €6.5M from investors like FG2 Capital, Lumen Ventures, Azimut Digitech Fund, and Invictus Capital to scale therapy access.[1] A pivotal 2024 €12M follow-on round, led by Angelini Ventures and CDP Venture Capital, fueled expansion, building on milestones like launching Serenis Business in 2023 for corporate programs and hitting nearly 1 million sessions.[2][4]
Core Differentiators
- Hybrid Tech-Therapist Model: Combines proprietary digital tools for data-driven matching of patients with 2,500+ certified professionals (average 13 years experience) to ensure optimal fits, outperforming generic platforms.[1][2]
- Affordability and Flexibility: Three free initial sessions per therapist (up to three changes), subsidized corporate access, and session-based pricing make high-quality care viable for broad audiences.[1][4]
- Corporate Wellbeing Focus: Serenis Business offers free/subsidized sessions, anonymous reporting, and impact metrics for 250+ clients, integrating mental health into workplaces.[2][4]
- Privacy, UX, and Community: Emphasizes data security, intuitive video platform, and massive outreach via TikTok, blog, and newsletter "Row" reaching 400K+ followers to destigmatize therapy.[1][4]
- Operational Efficiency: Tools like Pipedrive scaled therapist recruitment 300% in 8 months, enabling rapid network growth while maintaining quality.[5]
Role in the Broader Tech Landscape
Serenis rides the mental health tech boom within digital health, a sector with 11,315+ companies addressing emotional wellbeing via tech-enabled services amid post-pandemic demand surges.[3] Timing aligns with Italy's shifting attitudes—93% of workers prioritize workplace mental health—and global trends in accessible care, positioning Serenis against competitors like Centro Medico Santagostino by focusing on online scalability over physical clinics.[3][4] Market forces like rising corporate investments in employee wellbeing (e.g., via Serenis Business) and tech stigma reduction favor its hybrid model, influencing Italy's ecosystem by normalizing therapy through bold campaigns (Milan metro, trams) and building the largest mental health community.[1][2][4]
Quick Take & Future Outlook
Serenis is primed for pan-European expansion, leveraging its €40M+ 2025 run-rate, strengthened infrastructure from recent funding, and clinical enhancements to hit 1M+ sessions annually.[2][4] Trends like AI-driven personalization, corporate mandates for mental health, and BioTech/HealthTech convergence will propel growth, potentially evolving Serenis into a full-spectrum wellbeing leader influencing policy and standards.[2][3] With unmatched momentum in a high-demand market, it exemplifies how tech democratizes care—transforming Italy's silent mental health crisis into open access.